Abstract
Recent studies have implicated accelerated sarcolemmal phospholipid catabolism as a mediator of the lethal sequelae of atherosclerotic heart disease. We have demonstrated that plasmalogens are the predominant phospholipid constituents of canine myocardium and that plasmalogens are hydrolyzed by a novel calcium independent plasmalogen selective phospholipase A2. Since the activities of phospholipases are modulated by the molecular dynamics and interfacial characteristics of their phospholipid substrates, we compared the molecular dynamics of plasmenylcholine and phosphatidylcholine vesicles by electron spin resonance spectroscopy and deuterium magnetic resonance spectroscopy. Plasmenylcholine vesicles have separate and distinct molecular dynamics in comparisons to their phosphatidylcholine counterparts as ascertained by substantial decreases in the angular fluctuations and motional velocities of probes attached to their sn-2 aliphatic constituents. Furthermore, since free radical oxidation of myocardial lipid constituents occurs during myocardial ischemia and reperfusion, we demonstrated that 1O2 mediated oxidation of plasmenylcholine resulted in the generation of several products which have chromatographic characteristics and molecular masses corresponding to 2-acyl lysophosphatide derivatives. Taken together, these studies underscore the biologic significance of the predominance of sarcolemmal plasmalogens present in mammalian myocardium and suggest that their catabolism by plasmalogen selective phospholipases and/or oxidative processes may contribute to the lethal sequelae of myocardial ischemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sobel B, Corr P, Robison A, Goldstein R, Witkowski F, Klein M: Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest 62: 546–553, 1978
Corr P, Snyder D, Lee B, Gross R, Keim C, Sobel B: Pathophysiological concentrations of lysophosphatides and the slow response. Am J Physiol 243: H187-H195, 1982
Chien K, Reeves J, Buja L, Bonte F, Parkey R, Willerson J: Phospholipid alterations in canine ischemic myocardium: Temporal and topographical correlations with Tc-99m PPi accumulation and an in vitro sarcolemmal Ca 2+ permeability defect. Circ Res 48: 711–719, 1981
Idell-Wenger J, Grotyohann L, Neely J: Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310–4318, 1978
Hsueh W, Isakson P, Needleman P: Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins 13:1073–1091, 1977
Liedtke A, Nellis S, Neely J: Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Cir Res 43: 652–661, 1978
Neely J, Garber D, McDonough K, Idell-Wenger J: Relationship between ventricular function and intermediates of fatty acid metabolism during myocardial ischemia: Effects of carnitine. In Ischemic myocardium and antianginal drugs, edited by M. Winbury, Y Abiko, New York, Raven Press, 1979, pp 225–234
Oram J, Bennetch S, Neely J: Regulation of fatty acid utilization in isolated perfused rat hearts. J Biol Chem 248: 5299–5309, 1973
Corr P, Witkowski F, Sobel B: Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J Clin Invest 61: 109–119, 1978
Corr P, Snyder D, Cain M, Crafford Jr W, Gross R, Sobel B: Electrophysiological effects of amphiphiles on canine Purkinje fibers: Implications for dysrhythmia secondary to ischemia. Circ Res 49: 354–363, 1981
Clarkson C, Ten Eick R: On the mechanism of lysophosphatidylcholine-induced depolarization of cat ventricular myocardium. Circ Res 52: 543–556, 1983
Inoue D, Pappano A: L-Palmitoylcarnitine and calicum ions act similarly on excitatory ionic currents in avian ventricular muscle. Circ Res 52: 625–634, 1983
Arnsdorf M, Sawicki G: The effects of lysophosphatidylcholine, a toxic metabolite of ischemia, on the components of cardiac excitability in sheep Purkinje fibers. Circ Res 49: 16–30, 1981
Russell D, Oliver M, Wojtczak J: Combined clectrophysiological technique for assessment of the cellular basis of early ventricular arrhythmias: Experiments in dogs. Lancet 2: 686–688, 1977
Gross R, Sobel B: Lysophosphatidylcholine metabolism in the rabbit heart. Characterization of metabolic pathways and partial purification of myocardial lysophospholipasetransacylase. J Biol Chem 257: 6702–6708, 1982
Gross R, Sobel B: Rabbit myocardial cytosolic lysophospholipase: Purification, characterization, and competitive inhibition by L-palmitoyl carnitine. J Biol Chem 258: 5221–5226, 1983
Gross R, Drisdel R, Sobel B: Rabbit myocardial lysophospholipase-transacylase: Purification, characterization, and inhibition by endogenous cardiac amphiphiles. J Biol Chem 258: 15165–15172, 1983
Wolf RA, Gross RW: Identification of neutral active phospholipase C which hydrolizes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium. J Biol Chem 260: 7295–7303, 1985
Gross R, Corr P, Lee B, Saffitz J, Crafford Jr W, Sobel B: Incorporation of radiolabeled lysophosphatidyl choline in- to canine Purkinje fibers and ventricular muscle: Electrophysiological, biochemical, and autoradiographic correlations. Circ Res 51: 27–36, 1982
Knabb M, Saffitz J, Corr P, Sobel B: The dependence of electrophysiological derangements on accumulation of endogenous long-chain acyl carnitine in hypoxic neonatal rat myocytes. Circ Res 58: 230–240, 1986
Fink K, Gross R: Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds. Circ Res 55: 585–594, 1984
Gross R: High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: A fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization. Biochemistry 23: 158–165, 1984
Gross R: Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum. Biochemistry 24: 1662–1668, 1985
Wolf R, Gross R: Semi-synthetic approach for the preparation of homogeneous plasmenylethanolamine utilizing phospholipase D from Streptomyces Chromofuscus. J Lipid Res 26: 629–633, 1985
Pak J, Bork V, Norberg R, Creer M, Wolf R, Gross R: Disparate molecular dynamics of plasmenylcholine and phosphatidylcholine bilayers. Biochemistry 26: 4824–4830, 1987
Lucchesi B, Mullane K: Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol 26: 201–224, 1986
Rowe G, Manson N, Caplan M, Hess M: Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum: participation of the cyclooxygenase pathway. Circ Res 53: 584–591, 1983
Frimer A: Reaction of Singlet Oxygen with Olefins. Question of Mechanism. Chem Reviews 79: 359–386, 1979
Kanofsky J, Hoogland H, Wever R, Weiss S: Singlet oxygen production by human eosinophils. J Biol Chem 263: 9692–9696, 1988
Corey E, Mehrotra M, Khan A: Antiarthritic gold compounds effectively quench electronically excited singlet oxygen. Science 236: 68–69, 1987
Frimer A: In the chemistry of peroxides (Patai S, ed), pp 201–234, John Wiley & Sons, New York, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scherrer, L.A., Gross, R.W. Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium. Mol Cell Biochem 88, 97–105 (1989). https://doi.org/10.1007/BF00223430
Issue Date:
DOI: https://doi.org/10.1007/BF00223430